Does SIMVASTATIN Cause Pulmonary embolism? 254 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 254 reports of Pulmonary embolism have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.9% of all adverse event reports for SIMVASTATIN.
254
Reports of Pulmonary embolism with SIMVASTATIN
0.9%
of all SIMVASTATIN reports
163
Deaths
183
Hospitalizations
How Dangerous Is Pulmonary embolism From SIMVASTATIN?
Of the 254 reports, 163 (64.2%) resulted in death, 183 (72.0%) required hospitalization, and 129 (50.8%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 254 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which SIMVASTATIN Alternatives Have Lower Pulmonary embolism Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS